Key Players Driving the Intranasal Corticosteroids Market By 2023 to 2033

 

The global intranasal corticosteroids market demand is predicted to expand at a CAGR of 5.0% during the forecasted period, according to data from Future Market Insights. From US$ 6.8 billion in 2023 to US$ 11.2 billion in 2033, the market value is anticipated to rise. The market for intranasal corticosteroids was estimated to be worth US$ 6.5 billion at the end of 2022 and is expected to expand by 4.8% year over year in 2023.

The immunotherapy treatment segment is experiencing rapid growth in the market due to its high efficacy, despite the issue of high prices associated with this treatment. Manufacturers are actively focusing on developing targeted immunotherapy treatments to offset the decline in revenue caused by patent expiry.

Request A Sample Copy Of This Research Report! https://www.futuremarketinsights.com/reports/sample/rep-gb-9329

Companies are also strategically planning their product portfolio to align with the patent life cycle, filing for new patents based on dosage and prescription to maintain their market position. This is attributed to the increasing number of prescription drugs being switched to over-the-counter availability. Notably, the growing trend of self-medication in the United States presents a significant growth opportunity for manufacturers of allergic rhinitis treatment products.

In general, it is expected that the intranasal corticosteroid market will continue to experience growth in the coming years. This market offers customers an affordable and convenient option to enhance their smile.

Key Takeaways from Market Study:

  • Fluticasone Propionate lead the global market with 3% value share in 2022, owed to its effectiveness in reducing airway inflammation compared to other drugs.
  • The corticosteroids used for treatment of allergic rhinitis especially seasonal allergies top the sale around globe with value share of around 1% in 2022. This is due to the high amount of pollens release from plant, fungi, seeds during seasonal change.
  • Retail Pharmacies accounted for dominant market share for distribution of intranasal corticosteroids in 2022 with 7% value share. This can be attributed to the fact that retail pharmacies have a strong presence with numerous conveniently located branches in various neighborhood and communities allowing for easy accessibility and availability of drugs.
  • Intranasal sprays dominated globally with market share of around 3% in 2022, owed to easy administration of drugs into the nose.
  • In North America, the United States exhibited rising trend of intranasal corticosteroid usage due to over the counter self-medication purchase for treatment of rhinitis. U.S. market held a value share of around 3% in 2022 globally.

“Intranasal corticosteroids is a thriving market driven by rising allergic rhinitis cases, self-medication trends, making it profitable sector to venture by entrepreneurs ” says an analyst of Future Market Insights.

Market Competition:

Pharma industries are involved in research and development to make the corticosteroid delivery fast and with higher efficiency. The medications are also made cheaper with respect to pre-existing drug to reduce competition

  • In September 2022, Ryaltris has been approved by the US Food and Drug Administration, and it provides a wide variety of therapy options for children to the elderly, with the added bonus of having an onset of action of 15 minutes for nasal symptoms.

Key Companies Profiled:

  • Merck & co.
  • GlaxoSmithKline
  • AstraZeneca
  • Sanofi
  • Perrigo Co.
  • Teva Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • Mylan
  • Novartis
  • Pfizer
  • Pharmascience

Key Market Segments Covered in the Intranasal Corticosteroids Industry Research:

By Drug:

  • Fluticasone Propionate
  • Budesonide
  • Beclomethasone Dipropionate
  • Mometasone Furoate
  • Triamcinolone Acetonide
  • Ciclesonide
  • Flunisolide
  • Tixocortol

By Indication:

  • Allergic Rhinitis (AR)
    • Seasonal AR
    • Perennial AR
  • Non-Allergic Rhinitis (NAR)
    • Infectious NAR
    • Vasomotor NAR
    • Atrophic NAR

By Dosage Form:

  • Intranasal Drops
  • Intranasal Sprays

By Distribution Channel:

  • Hospitals Pharmacies
  • Drug Stores
  • Retail Pharmacies
  • Online Pharmacies

By Region:

  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa

Comments

Post a Comment

Popular posts from this blog

Teleradiology Services Market Analysis And Demand With Forecast Overview To 2032

Image
 In 2022, it is expected that the Teleradiology Services Market would be worth around US$ 31,880.57 Million. By 2032, it is anticipated that the market for teleradiology services would reach US$5,598.3 Million. with a 19% CAGR growth forecast through 2032. The global Teleradiology Services Market is estimated to reach a market valuation of US$ 1,971.4 Million by the end of 2016 and register a CAGR of 21.0% over the forecast period (2016–2026). The growth of this market can be attributed to the favorable government initiatives regarding the adoption of teleradiology in order to provide early disease diagnosis. Besides, the application of modern-day technologies such as the adoption of cloud-based technologies, blockchain, and cryptocurrencies will lead to better efficiency and cost-effective solutions. Increasing Investments for the development of advanced solutions is augmenting the demand for the industry. Request Sample PDF Brochure: https://www.futuremarketinsights.com/reports/...
Read more

Non-Vascular Stents Market to 2032 – Global Analysis and Forecasts by Types, Technologies, Applications and End-User Verticals

Image
 The Non-Vascular Stents Market is expected to grow at a CAGR of  4.5%  over the forecast period. (2022 - 2032). The sector is expected to be valued at  US$ 1.21 billion  in 2022 and  US$ 1.9 billion by 2032. The global non-vascular stents market is expected to move forward in response to the growing demand for minimally-invasive procedures. Rising technological and material advancements are assisting in the development of specially designed stents for use in a variety of indications thereby fueling the overall non-vascular stents market growth. Non-vascular stents use small, precise incisions, resulting in scars that are smaller and less visible than those left by traditional surgical techniques, putting the patient's safety in jeopardy. The above-mentioned feature is anticipated to provide impetus to the non-vascular stents market adoption trends in coming years. Such a surgery is associated with a faster recovery period, resulting in a shorter hospital ...
Read more

From X-rays to AI: Veterinary Imaging Innovations of the Next Decade By 2022 to 2030

Image
  Between 2022 and 2030, the global veterinary imaging industry is expected to grow at a CAGR of 6.6%, from US$ 2.02 billion in 2022 to US$ 3.37 billion by 2030. A study by Future Industry Insights (FMI) predicted that by 2030, the worldwide veterinary imaging industry would bring in US$ 3.37 billion. The research study looks at the market development for veterinary imaging through 2030 in more than 20 nations. The report offers precise insights into some of the key players in the industry's crucial business strategies. According to the poll, investments are being made in the veterinary diagnostics industry as the trend towards pet humanization picks up speed. Additionally likely to fuel industry growth are governmental rules and a greater emphasis on preserving animal health. Request A Report Sample To Gain Comprehensive Insights! https://www.futuremarketinsights.com/reports/sample/rep-gb-12368 Growth will also be fueled by the expansion of the animal and pet care industry as a w...
Read more